Module 1: Acute Management of Venous Thromboembolic Disease in the Hospitalized Patient: Challenges to Clinicians in the Care Transition Process

Summary

This is the first module in part of a two part series designed to improve the Transition of Care (ToC) process for the hospitalized patient with acute Venous Thromboembolic Disease (VTE). This module is designed as a supplement to the Society of Hospital Medicine's FAST (Facilitation of Anticoagulation for Safer Transition) Program Guide.

Learning Objectives

After completing the module, the participant will demonstrate the ability to:

  1. Define the scope of venous thromboembolic disease (VTED)
  2. Describe care deficits in the transitions of care process
  3. Describe key challenges in creation of optimal transitions of care in the hospitalized patient with acute VTED
  4. Review the current trends and gaps in care regarding the use of the direct oral anticoagulants (DOACs)
  5. Describe the implications for practice change related to the Joint Commission’s National Patient Safety Goal 3.05.01
  6. Review key elements for facilitating effective transitions of care in the anticoagulated patient with acute VTED

Release date: June 9, 2020

Expiration date: June 9, 2023

This activity is supported by an independent educational grant from Pfizer Inc.

Course summary
Course opens: 
06/09/2020
Course expires: 
06/09/2023
Member cost:
$0.00
Your cost:
$0.00
Part of: 
SHM FAST Program: Supplementary Series
Rating: 
0
Presenter

Lynda Thomson, PharmD, CACP
Advanced Practice Pharmacist
Departments of Pharmacy and Surgery
Jefferson Vascular Center
Thomas Jefferson University Hospital
Philadelphia, PA

Conflict Of Interest Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.

Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.

Price

Member cost:
$0.00
Your cost:
$0.00
Please login or register to take this course.

To begin the course, press START.